China Ups Penalties For Quality Violators Under Tougher Regulation
This article was originally published in The Tan Sheet
The China FDA has officially released a new regulation governing unannounced inspections for drug and device manufacturers, ranging from production to distribution to product use, with many expecting more frequent inspections and stricter enforcement. Although traditional medicine manufacturers are the main target for now, the scope of focus could be expanded.
Register for our free email digests: